Epilepsy Research 1993: Vol 16 Index

4 Pages·1993·0.84 MB·English

Epilepsy Research, 16 (1993) 247-249
0920-1211/93/$06.00 © 1993 Elsevier Science Publishers B.V. All rights reserved
Author Index to Volume 16 (1993)
Abou-Khalil, B., see Du, F., 223 Chadwick, D., see Jacoby, A., 83, 207
Andermann, E., see Cendes, F., 195 Chadwick, D.W., see Baker, G.A., 65
Andermann, F., see Cendes, F., 195 Colling, S.B., see Williams, S.F., 137
Antoniuk, S.A., see Bittencourt, P.R.M., 147 Corcoran, M.E., see McNamara, R.K., 15
Cukiert, A., see Cendes, F., 195
Baker, G., see Jacoby, A., 83, 207
Baker, G.A., Smith, D.F., Dewey, M., Jacoby, A. da Costa, J.C., see Bittencourt, P.R.M., 147
and Chadwick, D.W., The initial development of Dewey, M., see Baker, G.A., 65
a health-related quality of life model as an out- Dewey, M., see Jacoby, A., 83
come measure in epilepsy, 65 Doro, M.P., see Bittencourt, P.R.M., 147
Ben-Menachem, E., Hamberger, A. and Mumford, Drews, E., see Loscher, W., 183
J., Effect of long-term vigabatrin therapy on Dubeau, F., see Cendes, F., 195
GABA and other amino acid concentrations in Du, F., Whetsell Jr., W.O., Abou-Khalil, B., Blu-
the central nervous system — a case study, 241 menkopf, B., Lothman, E.W. and Schwarcz, R..,
Berger, A., see Weiss, S.R.B., 37 Preferential neuronal loss in layer III of the en-
Bigarella, M.M., see Bittencourt, P.R.M., 147 torhinal cortex in patients with temporal lobe
Bittencourt, P.R.M., Antoniuk, S.A., Bigarella, epilepsy, 223
M.M., da Costa, J.C., Doro, M.P., Ferreira, Duncan, J.S., see Sveinbjornsdottir, S., 165
A.S., Fonseca, L.C., Gorz, A.M., Gongalves e
Silva, G.E., Marcourakis, T. and _ Tedros, Emre, M., see Sveinbjornsdottir, S., 165
G.M.A.S., Carbamazepine and phenytoin in epi- Esplin, B., see Capek, R., 123
lepsies refractory to barbiturates: efficacy, toxi-
city and mental function, 147 Ferreira, A.S., see Bittencourt, P.R.M., 147
Blumenkopf, B., see Du, F., 223 Folbergrova, J., see Mare§, P., 11
Botez, M.I., Botez, T., Ross-Chouinard, A. and Fonseca, L.C., see Bittencourt, P.R.M., 147
Lalonde, R., Thiamine and folate treatment of
chronic epileptic patients: a controlled study Gaillard, W., see Theodore, W.H., 51
with the Wechsler IQ scale, 157 Gongalves e Silva, G.E., see Bittencourt, P.R.M..,
Botez, T., see Botez, M.I., 157 147
Buzsaki, G., see Kandel, A., 1 Gorz, A.M., see Bittencourt, P.R.M., 147
Gram, L., see Vorum, H., 55
Calvillo, M., Paz, C. and Sotelo, J., Changes in the
threshold of pentylenetetrazol-induced seizures in Hamberger, A., see Ben-Menachem, E., 241
cats with a chronic granuloma in brain amygda- Hirt, D., see Sveinbjornsdottir, S., 165
la, 45 Honack, D., see Léscher, W., 183
Capek, R. and Esplin, B., Frequency-dependent Honoré, B., see Vorum, H., 55
enhancement of hippocampal inhibition by
GABA uptake blockers, 123 Jacoby, A., see Baker, G.A., 65
Cendes, F., Dubeau, F., Olivier, A., Cukiert, A., An- Jacoby, A., Baker, G., Smith, D., Dewey, M. and
dermann, E., Quesney, L.F. and Andermann, F., Chadwick, D., Measuring the impact of epilepsy:
Increased neocortical spiking and surgical outcome the development of a novel scale, 83
after selective amygdalo-hippocampectomy, 195 Jacoby, A., Baker, G., Chadwick, D. and Johnson,
248
A., The impact of counselling with a practical Olivier, A., see Cendes, F., 195
statistical model on patients’ decision-making
about treatment for epilepsy: findings from a pi- Patsalos, P.N., see Sveinbjornsdottir, S., 165
lot study, 207 Paz, C., see Calvillo, M., 45
Jefferys, J.G.R., see Williams, S.F., 137 Piguet, P.. GABA,- and GABA g-mediated inhibi-
Johnson, A., see Jacoby, A., 207 tion in the rat dentate gyrus in vitro, 111
Post, R.M., see Weiss, S.R.B., 37
Kandel, A. and Buzsaki, G., Cerebellar neuronal
activity correlates with spike and wave EEG pat- Quesney, L.F., see Cendes, F., 195
terns in the rat, 1
Kapetanovic, I.M., see Torchin, C.D., 27 Reeves, P., see Theodore, W.H., 51
Kelly, K.M., see Rock, D.M., 89 Rock, D.M., Kelly, K.M. and Macdonald, R.L.,
Khan, I., see Theodore, W.H., 51 Gabapentin actions on ligand- and voltage-gated
Koryntova, H., see MareS, P., 11 responses in cultured rodent neurons, 89
Kubova, H., see MareS, P., 11 Rolf, L.H. and Voges, B., Effect of vigabatrin
Kupferberg, H.J., see Torchin, C.D., 27 (GVG) on serotonin (5-HT) uptake and release
of human platelets in vitro, 235
Lalonde, R., see Botez, M.I., 157 Ross-Chouinard, A., see Botez, M.I., 157
Leiderman, D., see Theodore, W.H., 51
Lewis, R., see Weiss, S.R.B., 37 Sander, J.W.A.S., see Sveinbjornsdottir, S., 165
Lloyd-Hontz, K., see Theodore, W.H., 51 Schielke, G.P., see Welty, D.., 175
Loéscher, W., see Wlaz, P., 131 Schwarcz, R., see Du, F., 223
Loéscher, W., Wahnschaffe, U., Ho6énack, D., Smith, D., see Jacoby, A., 83
Drews, E. and Nau, H., Effects of valproate and Smith, D.F., see Baker, G.A., 65
E-2-en-valproate on functional and morphologi- Sohn, E., see Weiss, S.R.B., 37
cal parameters of rat liver. III. Influence of fast- Sotelo, J., see Calvillo, M., 45
ing, 183 Stankova, L., see Mares, P., 11
Lothman, E.W., see Du, F., 223 Stringer, J.L., Alterations in both excitation and
Lowe, D., see Sveinbjornsdottir, S., 165 inhibition occur before the onset of seizure activ-
ity in the hippocampus, 99
Macdonald, R.L., see Rock, D.M., 89 Sveinbjornsdottir, S., Sander, J.W.A.S., Upton,
Marcourakis, T., see Bittencourt, P.R.M., 147 D., Thompson, P.J., Patsalos, P.N., Hirt, D.,
Mares, P., Kubova, H., Zouhar, A., Folbergrova, Emre, M., Lowe, D. and Duncan, J.S., The exci-
J., Koryntova, H. and Stankova, L., Motor and tatory amino acid antagonist D-CPP-ene (SDZ
electrocorticographic epileptic activity induced EAA-494) in patients with epilepsy, 165
by 3-mercaptopropionic acid in immature rats,
11 Taylor, C.P., see Welty, D.., 175
Matthew, E. and Woods, J.F., Growth hormone Tedros, G.M.A.S., see Bittencourt, P.R.M., 147
and prolactin in temporal lobe epilepsy, 215 Theodore, W.H., Leiderman, D., Gaillard, W.,
McNamara, R.K. and Corcoran, M.E., CL Khan, I., Reeves, P. and Lloyd-Hontz, K., The
218,872 a triazolopyridazine with a selective affi- effect of naloxone on cerebral blood flow and
nity for the benzodiazepine BZ, receptor sub- glucose metabolism in patients with complex par-
type, retards the development and expression of tial seizures, 51
amygdaloid-kindled seizures: effects of flumaze- Thompson, P.J., see Sveinbjornsdottir, S., 165
nil, 15 Torchin, C.D., Kapetanovic, I.M. and Kupferberg,
Mumford, J., see Ben-Menachem, E., 241 H.J., A system for testing the development and
reversal of anticonvulsant tolerance to benzodia-
Nau, H., see Léscher, W., 183 zepines in mice, 27
249
Upton, D., see Sveinbjornsdottir, S., 165 in rats: disequilibrium with peak drug concentra-
tions in plasma and brain microdialysate, 175
Vartanian, M.G., see Welty, D.., 175 Whetsell Jr., W.O., see Du, F., 223
Voges, B., see Rolf, L.H., 235 Whittington, M.A., see Williams, S.F., 137
Vorum, H., Gram, L. and Honoré, B., Valproate Williams, S.F., Colling, S.B., Whittington, M.A.
and palmitate binding to serum albumin in and Jefferys, J.G.R., Epileptic focus induced by
valproate-treated patients. Relation to obesity, intrahippocampal cholera toxin in rat: time
55 course and properties in vivo and in vitro, 137
Wlaz, P. and Léscher, W., The role of technical,
Wahnschaffe, U., see Loscher, W., 183 biological, and pharmacological factors in the
Weiss, S.R.B., Post, R.M., Sohn, E., Berger, A. laboratory evaluation of anticonvulsant drugs.
and Lewis, R., Cross-tolerance between carba- V. Lack of seasonal influences on amygdala
mazepine and valproate on amygdala-kindled kindling in rats, 131
seizures, 37 Woods, J.F., see Matthew, E., 215
Welty, D.., Schielke, G.P., Vartanian, M.G. and
Taylor, C.P., Gabapentin anticonvulsant action Zouhar, A., see Mare§, P., 11